Understanding hot flashes in prostate cancer
- The After Cancer
- 13 minutes ago
- 3 min read

Hot flashes are a common side effect for men undergoing androgen deprivation therapy (ADT) for prostate cancer.According to the Golden Gate Cancer Center, approximately 75–80% of men receiving ADT experience these sudden feelings of warmth, often accompanied by sweating and facial flushing.
What causes hot flashes in prostate cancer patients?
Hot flashes in prostate cancer patients are primarily due to reduced testosterone levels resulting from ADT. This hormonal change affects the hypothalamus, the brain's temperature regulation center, leading to sudden sensations of heat.
Testosterone Reduction and Hormonal Imbalance
Testosterone's Role: Testosterone, produced mainly in the testicles, plays a crucial role in various bodily functions, including the regulation of body temperature.
Impact of ADT: ADT aims to lower testosterone levels to inhibit prostate cancer cell growth. This reduction can disrupt the balance of other hormones and neurotransmitters involved in temperature regulation.
Hypothalamic Dysfunction
Hypothalamus Overview: The hypothalamus is a region in the brain responsible for maintaining homeostasis, including body temperature regulation.
Effect of Hormonal Changes: Reduced testosterone levels can affect the hypothalamus's ability to regulate body temperature effectively, leading to the onset of hot flashes.
Neurotransmitter Involvement
Role of Neurotransmitters: Neurotransmitters such as serotonin, norepinephrine, and GABA are involved in the regulation of body temperature.
Impact of Hormonal Changes: The hormonal fluctuations caused by ADT can alter the levels and activity of these neurotransmitters, contributing to the occurrence of hot flashes.
Endorphin Reduction
Endorphins and Temperature Regulation: Endorphins are neurotransmitters that can influence the body's response to temperature changes.
Consequences of Reduced Endorphins: A decrease in endorphin levels, resulting from hormonal changes due to ADT, may impair the body's ability to regulate temperature, leading to hot flashes.
Managing hot flashes
1. Pharmacological Treatments
Antidepressants: Selective serotonin reuptake inhibitors (SSRIs) like paroxetine and venlafaxine have shown efficacy in reducing hot flashes. The Oncology Nursing Society (ONS) guidelines recommend SSRIs like paroxetine and SNRIs such as venlafaxine as first-line treatments for hot flashes in men with prostate cancer, based on available evidence.
Clonidine: An alpha-2 adrenergic agonist that can alleviate hot flashes. However, the ONS guidelines classify clonidine as a second-line treatment for hot flashes in men with prostate cancer, suggesting its use when first-line agents are ineffective or not tolerated.
Gabapentinoids: Gabapentin has been evaluated for hot flash management, though its use is not universally recommended due to potential side effects. The American Cancer Society notes that gabapentin is commonly used off-label to treat hot flashes, including those related to cancer treatments.
2. Non-Pharmacological Approaches
Mindfulness and Cognitive Behavioral Therapy (CBT): These therapies can help patients manage stress and the emotional impact of hot flashes.
Cooling Devices: Innovative solutions like wrist-worn cooling devices have been explored for their feasibility in managing hot flashes.
Lifestyle Modifications: Adjustments such as wearing breathable clothing, maintaining a cool environment, and avoiding triggers like spicy foods and alcohol can help.
3. Alternative Therapies
Acupuncture: Some studies suggest that acupuncture may reduce the frequency and severity of hot flashes.
Herbal Supplements: While commonly used, the efficacy and safety of herbal remedies for hot flashes are not well-established, and they should be used cautiously.
Conclusion
Hot flashes are a significant concern for many men undergoing hormone therapy for prostate cancer. A combination of pharmacological treatments, non-pharmacological strategies, and lifestyle adjustments can effectively manage this side effect. It's important for patients to discuss these options with their healthcare providers to tailor a management plan that suits their individual needs.